Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
Tobias Tritschler, Leitender Arzt at Insel Gruppe, shared a post on LinkedIn about a recent article he and his collogues co-authored, published in JACC, adding:
“A long journey has come to an end.
This article brings together what we set out to do, but it also captures the challenges and precious lessons we learned along the way.
Our IPDMA shows that therapeutic-dose anticoagulation reduced the risk of organ support or death in noncritically ill patients hospitalized for COVID-19. More broadly, it illustrates how earlier coordination, data sharing, and evidence synthesis could have accelerated the translation of evidence into clinical practice during a public health emergency.
A heartfelt thank you to all investigators for your support, trust, patience, and commitment throughout this journey.
It was a privilege to work with you all.”
Title: Timing, Translation, and Preparedness: Lessons Learned From COVID-19 Anticoagulation in Noncritically Ill Hospitalized Patients
Authors: Tobias Tritschler, Valentin Fuster, Patrick R. Lawler, Michael E. Farkouh, Caterina E. Marx, Matthew D. Neal, Michelle Sholzberg, Alex C. Spyropoulos, Steven Y.C. Tong, Nuria Muñoz-Rivas, Marc Blondon, Jeffrey S. Berger, Behnood Bikdeli, Marco Cattaneo, Mary Cushman, Mark Goldin, Ewan C. Goligher, Judith S. Hochman, Peter Jüni, Zoe K. McQuilten, Nuccia Morici, Parham Sadeghipour, Balasubramanian Venkatesh, Stéphane Zuily, Alain Amstutz, Drahomir Aujesky, Marc Carrier, Robin V. Hofstetter, Srinivas Murthy, Marc Rodger, Leslie Skeith, Areti A. Veroniki, Brian Hutton, Ryan Zarychanski, Gregg W. Stone, and Grégoire Le Gal

Stay updated with Hemostasis Today.
-
Oct 30, 2026, 15:12Edward C.C. Wong: Navigating the Implications of the 2026 ASH Guidelines for Blood Donation
-
Oct 30, 2026, 14:53Pall T. Onundarson: Anticoagulation Guidelines Under the Influence of Pharmaceuticalisation
-
Oct 30, 2026, 14:27Isabella Presch: From Innovation to Accessibility in Cell and Gene Therapy
-
Oct 30, 2026, 14:00Abdul Mannan: A Negative PCR Does Not Exclude β-Thalassaemia
-
Oct 30, 2026, 13:53Matteo Foschi: Can Thrombolysis Safely Treat Stroke After Cardiac Procedures?
-
Oct 30, 2026, 13:42Wolfgang Miesbach: Gene Therapy-Associated Leukaemia With Clonal Persistence Over 16 Years
-
Oct 30, 2026, 12:47Louise St. Germain Bannon: Turning Thrombosis Awareness into Stroke Prevention
-
Oct 30, 2026, 12:36Aryabhatta Sadhu: Sickle Cell Crisis Recognising When Treatment Must Change
-
Oct 30, 2026, 12:22Fabrice Cognasse: The Future of Blood Banks From Transfusion Support to Precision Medicine